Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
- PMID: 31724069
- PMCID: PMC11804421
- DOI: 10.1007/s00432-019-03068-x
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
Abstract
Purpose: Growing solid tumors mostly outstrip blood supply and become hypoxic (low oxygen supply). To survive under this pathological milieu, tumors overexpress a potent oncogenic factor, hypoxia-inducible factor-1α (HIF-1α). HIF-1α up-regulate HIF-1 signaling pathways and subsequently activate genes that promote cancer growth even under hypoxia. Also, HIF-1 pathway activation leads to aggressive tumor growth, metastasis, therapy resistance and ultimately poor patient prognosis as evidential by several clinical studies. Hence, targeting HIF-1 pathway is regarded as a promising strategy to treat cancer. To date, several synthetic HIF-1 pathway inhibitors have been developed to treat hypoxic tumors; however, they are clinically ineffective due to off-target effects, low potency and high toxicity. Hence, there is an urgent need to explore safe and promising drugs to combat hypoxic tumors.
Results: This article extensively reviews the therapeutic potential of various herbal nutraceuticals against wide varieties of hypoxic tumors. The inhibitory effects of each herbal nutraceutical on the pathological consequences of HIF-1 signaling pathway and also their ability to improve the response of hypoxic cancer cells to conventional cancer therapies are discussed. Furthermore, we have provided new directions to overcome challenges behind conducting in vivo and preclinical hypoxia research and developing herbal nutraceuticals into pharmaceuticals to treat cancer.
Conclusions: The present review strongly suggests that herbal nutraceuticals are highly effective in combating the oncogenic effects of the HIF-1 pathway in wide varieties of tumors. However, more in vivo studies using zebrafish as a model system and extensive clinical studies in cancer patients with elevated tumor HIF-1α levels are highly warranted to ascertain the effective utilization of herbal nutraceuticals as adjunct/ alternative medicine in clinical practice to treat cancer.
Keywords: HIF-1 signaling pathway; HIF-1α; Herbal nutraceuticals; Tumor hypoxia.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Limning of HIF-2 and HIF-3 in the Tumor Microenvironment: Developing Concepts for the Treatment of Hypoxic Cancer.Curr Mol Med. 2025;25(5):513-521. doi: 10.2174/0115665240303179240427071748. Curr Mol Med. 2025. PMID: 38766832 Review.
-
Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in Glioblastoma Multiforme: a systematic review going beyond pathologic implications.Oncol Res. 2024 Jul 17;32(8):1239-1256. doi: 10.32604/or.2024.052130. eCollection 2024. Oncol Res. 2024. PMID: 39055895 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Herbal and dietary therapies for primary and secondary dysmenorrhoea.Cochrane Database Syst Rev. 2001;(3):CD002124. doi: 10.1002/14651858.CD002124. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2016 Mar 22;3:CD002124. doi: 10.1002/14651858.CD002124.pub2. PMID: 11687013 Updated.
-
Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1alpha.J Cancer Res Clin Oncol. 2010 Mar;136(3):447-56. doi: 10.1007/s00432-009-0675-4. Epub 2009 Sep 16. J Cancer Res Clin Oncol. 2010. PMID: 19760195 Free PMC article.
Cited by
-
Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors.ACS Med Chem Lett. 2022 Sep 13;13(12):1864-1869. doi: 10.1021/acsmedchemlett.2c00308. eCollection 2022 Dec 8. ACS Med Chem Lett. 2022. PMID: 36518694 Free PMC article.
-
The role of plant-derived natural substances as immunomodulatory agents in carcinogenesis.J Cancer Res Clin Oncol. 2020 Dec;146(12):3137-3154. doi: 10.1007/s00432-020-03424-2. Epub 2020 Oct 15. J Cancer Res Clin Oncol. 2020. PMID: 33063131 Free PMC article. Review.
-
Crocetin and related oxygen diffusion-enhancing compounds: Review of chemical synthesis, pharmacology, clinical development, and novel therapeutic applications.Drug Dev Res. 2021 Nov;82(7):883-895. doi: 10.1002/ddr.21814. Epub 2021 Apr 4. Drug Dev Res. 2021. PMID: 33817811 Free PMC article. Review.
-
Updated Review on the Role of Curcumin in Gastrointestinal Cancers.Adv Exp Med Biol. 2021;1308:55-89. doi: 10.1007/978-3-030-64872-5_6. Adv Exp Med Biol. 2021. PMID: 33861437 Review.
-
Anti-hypoxic Effect of Polysaccharide Extract of Brown Seaweed Sargassum dentifolium in Tongue Squamous Cell Carcinoma.Front Nutr. 2022 Mar 24;9:854780. doi: 10.3389/fnut.2022.854780. eCollection 2022. Front Nutr. 2022. PMID: 35399691 Free PMC article.
References
-
- Ansó E, Zuazo A, Irigoyen M, Urdaci MC, Rouzaut A, Martínez-Irujo JJ (2010) Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. Biochem Pharmacol 79(11):1600–1609 - PubMed
-
- Anubhuti Sh, Ashok Sh, Prashant Y, Dhiraj S (2016) Isothiocyanates in brassica: potential anti cancer agents. Asian Pac J Cancer Prev 17(9):4507–4510 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical